CDXC May 2024 5.000 put
| Previous Close | 1.2400 |
| Open | 1.2400 |
| Bid | 1.1500 |
| Ask | 1.5500 |
| Strike | 5.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 1.2400 - 1.2400 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 8 |
Business WireChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
LOS ANGELES, April 30, 2024--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces an ingredient partnership with Solgar®, a Nestlé Health Science brand. Solgar’s inaugural NAD+ supplement, Solgar Cellular Nutrition Cellular Energy, features ChromaDex’s patented nicotinamide riboside (NR) ingredient, NIAGEN® to support NAD+ levels for cellular health. This product marks a significant milestone in the health and welln
Business WireChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
LOS ANGELES, April 25, 2024--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces that its flagship consumer supplement, Tru Niagen®, is now available at The Vitamin Shoppe retail locations nationwide and online at www.vitaminshoppe.com. This retail expansion adds Tru Niagen to the shelves of 700 locations of The Vitamin Shoppe and Super Supplements, enhancing consumer access to the number one healthy-aging NAD+ sup
Business WireChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
LOS ANGELES, April 24, 2024--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announced that it will hold a conference call on Wednesday, May 8, 2024 at 4:30 p.m. ET to discuss its financial results for the first quarter, which ended March 31, 2024. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.
